This medium is optimized for the culture of our stable recombinant HEK293 cells (Type-A). This is a ready-to-use medium including selection antibiotics for maintenance of stabe recombinant target expression.
Characteristics
- Ready-to-use medium
- Contains serum
- Expansion medium
Contents
- 500ml Ready-to-use Medium
Cell Lines
- Stable recombinant HEK293 (Type-A)
Composition
The complete formulation is available in the FAQ below.
Buying and Ordering
To request a quote, please email us at or use the contact form provided below.
We are already registered on several digital order processing platforms, if you would like to add us as a registered supplier, please contact us at and we are happy to help.
Product Details
HEK293 Growth Medium A is a specially developed HEK293 growth medium for the in vitro culture of our stable recombinant HEK293 cells (Type-A). The Product Sheet of the respective cell line will indicate the appropriate cell culture medium for each respective stable recombinant HEK293 cell line.
It is designed for use in an incubator at 37° C with a 5% CO2 atmosphere.
This Medium is provided as a ready-to-use medium.
This medium already contains selection antibiotics for the maintenance of recombinant target expression.
Store the products as follows if not indicated otherwise on the product label.
Ready-to-use Medium at 4 to 8°C
Please see the product label for the expiry date of your product.
Material Safety Data Sheet (MSDS) – coming soon!
Medium composition – coming soon!
Related Products
Product FAQ
Yes, this Medium is supplied ready-to-use and can be used as is for culture of stable recombinant CHO cells (Type-A).
Yes, this medium contains 10% bovine serum.
Basal medium: RPMI 1640 Medium (2g/L Glucose, 2.0mM Glutamine)
Supplements:
- 10% (v/v) FBS/FCS
- 1.0mg/ml Geneticin (G418 Sulfat)
- 1mM Sodium Pyruvate
- 10mM HEPES
- 1x Non-essential amino acids
This medium contains no prophylactic antibiotics to prevent bacterial or fungal contamination. However, it does contain a selection antibiotic for maintenance of stable recombinant target expression.